Wenhu Pi
Overview
Explore the profile of Wenhu Pi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
738
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ding J, Wang X, Yang H, Zhang L, Ying Y, Pi W, et al.
Cancer Sci
. 2025 Jan;
PMID: 39805702
Lymph node metastasis significantly affects the NSCLC patients' staging, treatment strategy, and prognosis. Studies have shown that IGF2BP3, an oncofetal protein and an m6A reader, overexpresses and correlates to lymph...
2.
Li S, Chen K, Sun Z, Chen M, Pi W, Zhou S, et al.
Expert Rev Mol Med
. 2024 Oct;
26:e30.
PMID: 39438247
Radiotherapy (RT) plays a key role in the tumour microenvironment (TME), impacting the immune response via cellular and humoral immunity. RT can induce local immunity to modify the TME. It...
3.
Lan Y, Pi W, Zhou Z, Meng Y, DanMei , Xu Y, et al.
Int Immunopharmacol
. 2023 Sep;
124(Pt B):110956.
PMID: 37751656
Radiotherapy (RT) is the mainstay treatment modality for lung cancer. We recently reported that conventionally fractionated radiotherapy (CRT) with daily fractionation of 2Gy significantly increased the activity of indoleamine 2,3-dioxygenase...
4.
Xia X, Pi W, Chen M, Wang W, Cai D, Wang X, et al.
Front Oncol
. 2023 Aug;
13:1216131.
PMID: 37576883
Pleckstrin homologous domain leucine-rich repeating protein phosphatases (PHLPPs) were originally identified as protein kinase B (Akt) kinase hydrophobic motif specific phosphatases to maintain the cellular homeostasis. With the continuous expansion...
5.
Liu X, Li D, Pi W, Wang B, Xu S, Yu L, et al.
Int Immunopharmacol
. 2022 Nov;
113(Pt A):109379.
PMID: 36330913
Doxorubicin (DOX) is an effective and widely used anticancer drug but has limited clinical applicability because of its cardiotoxicity. Ferroptosis plays a key role in DOX-induced cardiac damage and cardiomyocyte...
6.
Xia X, Pi W, Lan Y, Wu X, Lv D, Meng Y, et al.
Anal Cell Pathol (Amst)
. 2022 Jun;
2022:4484211.
PMID: 35757014
Background: Small-molecule tyrosine inhibitor anlotinib which developed in China has been approved as a third-line treatment for patients with small-cell lung cancer (SCLC). Our previous clinical study found that anlotinib...
7.
Li D, Pi W, Sun Z, Liu X, Jiang J
Biomed Pharmacother
. 2022 Jun;
153:113279.
PMID: 35738177
Heart disease is the leading cause of death worldwide. Cardiomyopathy is a disease characterized by the heart muscle damage, resulting heart in a structurally and functionally change, as well as...
8.
Li D, Liu X, Pi W, Zhang Y, Yu L, Xu C, et al.
Front Pharmacol
. 2022 Mar;
12:808480.
PMID: 35273493
Doxorubicin (DOX) is an anthracycline antibiotic that is used extensively for the management of carcinoma; however, its clinical application is limited due to its serious cardiotoxic side effects. Ferroptosis represents...
9.
Zhang H, Wang W, Pi W, Bi N, DesRosiers C, Kong F, et al.
Front Oncol
. 2021 Jul;
11:599719.
PMID: 34307117
Transforming growth factor-β1 (TGF-β1), a known immune suppressor, plays an important role in tumor progression and overall survival (OS) in many types of cancers. We hypothesized that genetic variations of...
10.
Wang W, Huang L, Jin J, Pi W, Ellsworth S, Jolly S, et al.
Clin Cancer Res
. 2019 Sep;
26(1):282-289.
PMID: 31471311
Purpose: We recently reported that indoleamine 2, 3-dioxygenase (IDO) activity is significantly correlated with more distant metastasis and worse survival. The present study examined whether radiotherapy (RT) dose fractionation correlates...